Your session is about to expire
← Back to Search
Behavioural Intervention
Teleexercise Methods for Improving Physical Activity (FITWITHUS Trial)
N/A
Recruiting
Led By Mohanraj Thirumalai, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have a permanent mobility impairment
Age 18 to 64 years
Must not have
Significant visual acuity that prevents seeing a computer screen to follow a home exercise program
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 32
Awards & highlights
No Placebo-Only Group
Summary
This trial is a 32-week study that aims to determine the best way to deliver teleexercise combined with predictive analytics for physical activity interventions. All participants will have access to exercise videos and wellness articles.
Who is the study for?
This trial is for individuals aged 18 to 64 with permanent mobility impairments who have internet access and can converse in English. It's not suitable for those who've been exercising regularly for the past 6 months or have significant visual issues preventing them from seeing a computer screen.
What is being tested?
The study tests various sequences of delivering teleexercise and health coaching, using SMART design to adapt interventions based on participant adherence. Participants will receive different combinations of recorded content, live training, and health coaching over a period of 32 weeks.
What are the potential side effects?
Since this trial involves physical activity programs delivered via telemedicine, potential side effects may include muscle soreness, fatigue, or injury related to exercise. The intensity of these side effects can vary depending on individual fitness levels.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a long-term disability that affects my ability to move.
Select...
I am between 18 and 64 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot see well enough to follow exercises on a computer screen.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 32
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~32
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adherence
Secondary study objectives
cost effectiveness
effectiveness
physical activity and fatigue
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
6Treatment groups
Experimental Treatment
Group I: asynchronous exercise responderExperimental Treatment1 Intervention
Individuals only receiving asynchronous exercise content and are responding
Group II: Asynchronous exercise non-responder and group live trainingExperimental Treatment1 Intervention
Individuals receiving asynchronous exercise content and are not responding. The are receiving group live exercise sessions.
Group III: Asynchronous exercise non-responder and 1 on 1 live trainingExperimental Treatment1 Intervention
Individuals receiving asynchronous exercise content and are not responding. The are receiving 1 on 1 live exercise sessions.
Group IV: Asynchronous exercise and health coaching responderExperimental Treatment1 Intervention
Individuals receiving asynchronous exercise content and health coaching and are responding
Group V: Asynchronous exercise and health coaching non-responder and group live trainingExperimental Treatment1 Intervention
Individuals receiving asynchronous exercise content and health coaching and are not responding. The are receiving group live exercise sessions.
Group VI: Asynchronous exercise and health coaching non-responder and 1 on 1 live trainingExperimental Treatment1 Intervention
Individuals receiving asynchronous exercise content and health coaching and are not responding. The are receiving 1 on 1 live exercise sessions.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,656 Previous Clinical Trials
2,444,118 Total Patients Enrolled
Mohanraj Thirumalai, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham
2 Previous Clinical Trials
83 Total Patients Enrolled